SG Americas Securities’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $600K | Buy |
19,177
+10,522
| +122% | +$329K | ﹤0.01% | 1393 |
|
|
2025
Q1 | $290K | Sell |
8,655
-4,638
| -35% | -$155K | ﹤0.01% | 1996 |
|
|
2024
Q4 | $521K | Buy |
13,293
+5,577
| +72% | +$219K | ﹤0.01% | 1135 |
|
|
2024
Q3 | $304K | Sell |
7,716
-18,463
| -71% | -$727K | ﹤0.01% | 1894 |
|
|
2024
Q2 | $1.02M | Buy |
26,179
+5,813
| +29% | +$227K | 0.01% | 1186 |
|
|
2024
Q1 | $877K | Buy |
20,366
+1,760
| +9% | +$75.8K | ﹤0.01% | 1072 |
|
|
2023
Q4 | $857K | Sell |
18,606
-38,146
| -67% | -$1.76M | 0.01% | 993 |
|
|
2023
Q3 | $1.94M | Buy |
56,752
+17,490
| +45% | +$598K | 0.02% | 691 |
|
|
2023
Q2 | $1.51M | Buy |
39,262
+13,385
| +52% | +$515K | 0.01% | 788 |
|
|
2023
Q1 | $926K | Sell |
25,877
-9,588
| -27% | -$343K | 0.01% | 1079 |
|
|
2022
Q4 | $1.4M | Buy |
35,465
+13,633
| +62% | +$537K | 0.02% | 649 |
|
|
2022
Q3 | $788K | Sell |
21,832
-621
| -3% | -$22.4K | 0.01% | 1025 |
|
|
2022
Q2 | $683K | Buy |
+22,453
| New | +$683K | 0.01% | 1511 |
|